Reta | GLP3

R3TA is a next-generation research peptide that has generated significant interest within the scientific community due to its unique interaction with three key metabolic pathways. As a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, RETA is being extensively studied for its potential role in energy regulation, metabolic function, and body composition research.

Researchers have explored RETA for its effects on appetite signalling, glucose metabolism, fat oxidation, and overall energy balance. Its multi-pathway mechanism distinguishes it from traditional single-target compounds, making it a prominent focus in ongoing metabolic and endocrine research.

Due to its broad activity across several biological systems, RETA continues to be investigated for its potential impact on metabolic flexibility, insulin sensitivity, and weight management models. As one of the most innovative compounds in modern peptide research, it remains at the forefront of studies examining metabolism, energy utilization, and long-term metabolic health.